ADVANCEMENT OF A TISSUE OXYGENATION MEASUREMENT DEVICE AND EVALUATION OF GALECTIN-3 AS NOVEL NONINVASIVE PROGNOSTIC BIOMARKERS FOR MONITORING VCA REJECTION
$1,197,199FY2022Defense Health AgencyDOD
The Regents Of The University Of Colorado
The Regents Of The University Of Colorado